This Monday, Albert Bourla, the chief executive of pharmaceuticals group Pfizer PFE, sold some of his shares in the company and pocketed some $5.6 million in the process.
As it happens, it was also the day when the U.S. group and its German partner BioNTech BNTX announced that their experimental coronavirus vaccine had achieved 90%-plus efficacy…
